Responses and outcomes in the RTX + TPO and RTX groups
| . | RTX + rhTPO . | RTX . | P . |
|---|---|---|---|
| CR, % (n) | 45.4 (35) | 23.7 (9) | .026* |
| R, % (n) | 33.8 (26) | 47.4 (18) | .22 |
| OR, % (n) | 79.2 (61) | 71.1 (27) | .36 |
| NR, % (n) | 20.8 (16) | 28.9 (11) | .36 |
| For patients with an initial response | |||
| TTR (days), median (range) | 7 (4-28) | 28 (4-90) | .004† |
| Duration of response (≥6 mo), % (n) | 67.2 (41) | 55.6 (15) | .34 |
| Duration of response (≥12 mo), % (n) | 44.3 (27) | 29.6 (8) | .24 |
| Duration of response (≥24 mo), % (n) | 24.6 (15) | 18.5 (5) | .59 |
| . | RTX + rhTPO . | RTX . | P . |
|---|---|---|---|
| CR, % (n) | 45.4 (35) | 23.7 (9) | .026* |
| R, % (n) | 33.8 (26) | 47.4 (18) | .22 |
| OR, % (n) | 79.2 (61) | 71.1 (27) | .36 |
| NR, % (n) | 20.8 (16) | 28.9 (11) | .36 |
| For patients with an initial response | |||
| TTR (days), median (range) | 7 (4-28) | 28 (4-90) | .004† |
| Duration of response (≥6 mo), % (n) | 67.2 (41) | 55.6 (15) | .34 |
| Duration of response (≥12 mo), % (n) | 44.3 (27) | 29.6 (8) | .24 |
| Duration of response (≥24 mo), % (n) | 24.6 (15) | 18.5 (5) | .59 |